Consistent with our previous studies using the HYD1 linear analog of MTI-10115, MTI-101 was significantly more potent (p < 0.05, Student’s t-test) in relapsed than newly diagnosed MM specimens (Fig. 6A). Here, MSX1 is linked to Miyoshi myopathy.